Solvotrin Therapeutics Competitors and Similar CompaniesClear all

Solvotrin Therapeutics's competitors and similar companies include Vertex Pharmaceuticals, Livzon Pharmaceutical Group and Alembic Pharmaceuticals.
Solvotrin Therapeutics
Solvotrin Therapeutics
Solvotrin Therapeutics is a drug development company focused on chemical modifications of known drugs.
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
Alembic Pharmaceuticals
Alembic Pharmaceuticals
Alembic Pharmaceuticals is a company that manufactures branded formulations, international generics, and APIs (active pharmaceutical ingredients).
Founding Date
Founding Date
2009
Founding Date
1989
Founding Date
1985
Founding Date
1907
Type
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
IE HQ
Locations
Boston, US HQ
St Leonards, AU
Wien, AT
Bruxelles, BE
São Paulo, BR
Toronto, CA
Praha, CZ
see more
Locations
Zhuhai, CN HQ
Chengdu, CN
Qingyuan, CN
Shanghai, CN
Shaoguan, CN
Shenzhen, CN
Zhuhai, CN
Locations
Vadodara, IN HQ
Mumbai, IN
Vadodara, IN
Employees
Employees
225% increase
Employees
5,40013% increase
Employees
8,933
Employees
14,8582% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
123.5 b
Valuation ($)
4.1 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$9.9b (FY, 2023)
Revenue (est.)
¥12.2b (FY, 2023)
Revenue (est.)
₹61.1b (FY, 2024)
Cost of goods
Cost of goods
N/A
Cost of goods
$1.3b (FY, 2023)
Cost of goods
¥4.5b (FY, 2023)
Cost of goods
₹19.3b (FY, 2024)
Gross profit
Gross profit
N/A
Gross profit
$8.6b (FY, 2023)
Gross profit
¥7.8b (FY, 2023)
Gross profit
₹43b (FY, 2024)
Net income
Net income
N/A
Net income
$3.6b (FY, 2023)
Net income
¥1.9b (FY, 2023)
Net income
₹6.2b (FY, 2024)

Funding

Total funding raised
Total funding raised
$ 4.4m
Total funding raised
$ 2.4m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Vertex Pharmaceuticals
HQ
Boston, US
Employees
5,400↑ 13% increase

Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.

View company
Livzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
8,933

Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.

View company
Alembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858↑ 2% increase

Alembic Pharmaceuticals is a company that manufactures branded formulations, international generics, and APIs (active pharmaceutical ingredients).

View company